---
$id: https://graph.org.ai/products/commodity/51111824
$type: Product
source: UNSPSC
code: "51111824"
title: "Exemestane"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Exemestane

**UNSPSC Code**: 51111824
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a steroidal aromatase inhibitor with the molecular formula C20H24O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier NY22HMQ4BX, chemically known as 6-methyleneandrosta-1,4-diene-3,17-dione but generally known as exemestane, which bears US NIH Compound Identifier 60198. European Medicines Agency schedules Exemestane in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07492MIG. The term EXEMESTANE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 6, No, 3 1992, List 32). World Health Organization schedules exemestane in its Anatomical Therapeutic Chemical (ATC) Classification. EXEMESTANE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule exemestane under HS 29372900 and SITC 54153. As of Q4 2014, EXEMESTANE remains the US FDA Preferred Term for this commodity. Exemestane bears US NLM identifiers UMLS ID C0851344 and NCI Concept Code C1097. SMILES: O=C1C2(C(C3C(CC2)C2(C(=CC(=O)C=C2)C(=C)C3)C)CC1)C.

